Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.18 +0.03 (+2.61%)
As of: Oct 2, 2026 · 12:51 PM EDT

Actinium Pharmaceuticals (ATNM) Accumulated Expenses (2010 - 2018)

Updated

Actinium Pharmaceuticals' Accumulated Expenses was $15,000 in Q3 2018, down 66.7% from $45,000 a year earlier.

Analysis

Actinium Pharmaceuticals (ATNM) Accumulated Expenses (2010 - 2018) Analysis & Trends

At the end of FY2012, Accumulated Expenses at Actinium Pharmaceuticals came in at $1,090.

  • In earlier years, Accumulated Expenses was $300.00 in FY2011 (-73.2%) and $1,120 in FY2010.
  • The Q3 2018 figure marks the lowest quarterly Accumulated Expenses since Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Actinium Pharmaceuticals 36.16 Mn 36.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 15,000.00
Sep 30, 2017 45,000.00
Jun 30, 2017 44,000.00
Sep 30, 2012 1,090.00
Jun 30, 2012 550.00
Mar 31, 2012 1,710.00
Dec 31, 2011 300.00
Sep 30, 2011 1,740.00
Jun 30, 2011 810.00
Dec 31, 2010 1,120.00
API Access

Actinium Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ATNM&period=max&api_key=YOUR_API_KEY